+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Human Type I Collagen Market - Global Forecast 2026-2032

  • Report

  • 180 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6123251
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Human Type I Collagen Market is projected to reach USD 5.09 Billion in 2026. It is expected to continue growing at a CAGR of 13.67%, reaching USD 11.24 Billion by 2032.

Human Type I Collagen: Executive Overview

Human Type I collagen is a structural protein used in applications where biocompatibility, tissue interaction, and controlled material performance are important. Its relevance spans regenerative medicine, wound care, biomaterials, research, and selected aesthetic or pharmaceutical uses. Demand conditions are shaped by clinical evidence, regulatory requirements, manufacturing consistency, donor or source considerations, and the ability to demonstrate safety and functional performance.

Clinical Validation and Manufacturing Rigor Are Reshaping the Landscape

The landscape is shifting toward higher standards for traceability, characterization, sterility assurance, and batch-to-batch consistency. Developers and buyers increasingly assess collagen by source transparency, purity, mechanical behavior, degradation profile, and compatibility with intended use rather than by material availability alone. Advances in tissue engineering and wound management are also encouraging more application-specific formulations, including scaffolds, coatings, membranes, hydrogels, and composite biomaterials.

Artificial Intelligence Accelerates Discovery, Quality Control, and Personalization

Artificial intelligence can improve human Type I collagen development by analyzing experimental datasets, identifying relationships between processing conditions and material properties, and supporting formulation optimization. Computer vision and machine-learning systems may assist with imaging-based quality assessment, defect detection, and release testing when validated against established laboratory methods. In clinical and translational settings, AI can help stratify patients, interpret tissue-response data, and refine scaffold designs, but adoption depends on representative datasets, explainability, cybersecurity, and compliance with applicable medical-device and pharmaceutical controls.

Regional Insights: Regulation, Clinical Infrastructure, and Supply Resilience

North America combines advanced biomedical research with demanding regulatory and quality expectations. Europe emphasizes harmonized standards, ethical sourcing, and traceability across the European market. Asia-Pacific benefits from expanding biotechnology capabilities, research activity, and healthcare infrastructure, while regulatory maturity varies among countries. Latin America presents opportunities linked to reconstructive care, research partnerships, and local manufacturing, alongside differences in reimbursement and approval pathways. The Middle East is investing in specialized healthcare and biotechnology capacity, with procurement often influenced by import dependence and national development programs. Africa shows uneven access to advanced biomaterials, making affordability, training, supply reliability, and adaptable clinical use particularly important.

Group Insights: Different Blocs Shape Access and Compliance

ASEAN markets reflect varied regulatory systems, healthcare capacity, and manufacturing bases, creating a need for locally appropriate registration and distribution strategies. BRICS economies combine substantial scientific and industrial capabilities with diverse approval, procurement, and reimbursement environments. The European Union prioritizes coordinated regulatory compliance, quality systems, and cross-border documentation. G7 countries generally emphasize clinical validation, advanced manufacturing, and stringent safety oversight. GCC markets are influenced by centralized procurement, healthcare modernization, and import considerations. NATO members span multiple regulatory jurisdictions, but many share strong requirements for supply continuity, medical quality management, and trusted biomedical sourcing.

Country Insights: National Priorities Determine Adoption Conditions

Australia supports biomedical research and regulated healthcare adoption, with attention to evidence and institutional procurement. Brazil and Mexico are influenced by public-health access, import processes, and the development of domestic capabilities. Canada and the United States maintain strong research ecosystems and rigorous product oversight. China and India combine expanding biotechnology activity with complex, evolving regulatory environments and significant demand for scalable healthcare solutions. Japan and South Korea emphasize precision manufacturing, advanced clinical research, and quality assurance. France, Germany, Italy, Spain, and the United Kingdom are shaped by sophisticated healthcare systems, formal evidence requirements, and sustainability or traceability expectations. Russia’s operating environment is affected by regulatory, trade, and supply-chain constraints, requiring careful assessment of sourcing and compliance conditions.

Industry Leaders Should Prioritize Evidence, Traceability, and Resilience

Leaders should define product specifications around the intended clinical or research use, then build evidence packages that connect composition, processing, performance, and safety. Establishing robust supplier qualification, documented chain of custody, validated sterilization, and risk-based quality controls can reduce operational uncertainty. Partnerships with hospitals, universities, and specialized laboratories can strengthen translational evidence, while region-specific regulatory planning can shorten avoidable delays. Organizations should also evaluate AI selectively, beginning with quality or discovery applications that have clear validation criteria, human oversight, and documented governance.

Research Methodology: Structured Synthesis of Verified Market Drivers

This executive summary uses the market definition of human Type I collagen and organizes evidence around application requirements, regulatory conditions, manufacturing practices, healthcare infrastructure, technology adoption, and geographic operating environments. Insights are developed through structured comparison of the specified regions, country groups, and countries, with emphasis on verifiable qualitative drivers rather than unsupported numerical claims. The assessment excludes market estimates, market shares, forecasts, and company-specific conclusions, and treats regional variation, evidence quality, and regulatory context as central interpretation criteria.

Conclusion: Adoption Depends on Trusted Performance and Responsible Scale

Human Type I collagen is positioned at the intersection of biomaterials science, regenerative medicine, and regulated healthcare. Its advancement will depend on reproducible manufacturing, transparent sourcing, clinically relevant validation, and compatibility with regional requirements. Organizations that combine scientific rigor with resilient supply planning, responsible AI adoption, and application-focused partnerships will be better prepared to translate collagen-based technologies into dependable research and healthcare solutions.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Human Type I Collagen Market, by Form
7.1. Introduction
7.2. Film
7.3. Gel
7.4. Liquid
7.5. Powder
7.6. Scaffold
8. Human Type I Collagen Market, by Production Technique
8.1. Introduction
8.2. Extraction Purification
8.2.1. Acid Solubilization
8.2.2. Enzymatic Hydrolysis
8.3. Recombinant Expression
8.3.1. Bacterial Expression
8.3.2. Mammalian Expression
8.3.3. Yeast Expression
9. Human Type I Collagen Market, by Product Grade
9.1. Introduction
9.2. Cosmetic Grade
9.3. Laboratory Grade
9.4. Medical Grade
9.5. Nutraceutical Grade
10. Human Type I Collagen Market, by Application
10.1. Introduction
10.2. Cosmetic Formulations
10.2.1. Anti-Aging
10.2.2. Skincare
10.3. Dental Applications
10.3.1. Dental Implants
10.3.2. Periodontal Regeneration
10.4. Drug Delivery
10.4.1. Controlled Release
10.4.2. Targeted Delivery
10.5. Orthopedic Implants
10.5.1. Bone Grafting
10.5.2. Tendon Repair
10.6. Wound Care
10.6.1. Acute Wounds
10.6.2. Chronic Wounds
10.6.3. Surgical Wounds
11. Human Type I Collagen Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Cosmetic Companies
11.4. Hospitals
11.5. Pharmaceutical Companies
11.6. Research Institutes
12. Human Type I Collagen Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Human Type I Collagen Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Human Type I Collagen Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Advanced BioMatrix, Inc.
16.2. B. Braun Melsungen AG
16.3. Biomatlante
16.4. Botiss Biomaterials GmbH
16.5. Collagen GmbH
16.6. Collagen Matrix, Inc.
16.7. Collagen Solutions plc
16.8. CollPlant Biotechnologies Ltd.
16.9. Covalon Technologies Ltd.
16.10. Devro plc
16.11. DSM Biomedical
16.12. EnColl Corporation
16.13. FibroGen, Inc.
16.14. Gurnet Point Capital
16.15. Integra LifeSciences Corporation
16.16. Jellagen Pty Ltd
16.17. Kensey Nash Corporation
16.18. Medtronic plc
16.19. Regenity Biosciences
16.20. Sunmax Biotechnology Co., Ltd.
16.21. Viscofan BioEngineering
16.22. Xylos Corporation
16.23. Zimmer Biomet Holdings, Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Human Type I Collagen Market, Years Considered for the Study
FIGURE 2. Global Human Type I Collagen Market, Research Design
FIGURE 3. Global Human Type I Collagen Market, Research Framework
FIGURE 4. Global Human Type I Collagen Market, Data Triangulation
FIGURE 5. Global Human Type I Collagen Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Human Type I Collagen Market Size, by Form, 2025 vs 2032 (%)
FIGURE 7. Global Human Type I Collagen Market Size, by Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Human Type I Collagen Market Size, by Production Technique, 2025 vs 2032 (%)
FIGURE 9. Global Human Type I Collagen Market Size, by Production Technique, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Human Type I Collagen Market Size, by Product Grade, 2025 vs 2032 (%)
FIGURE 11. Global Human Type I Collagen Market Size, by Product Grade, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Human Type I Collagen Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Human Type I Collagen Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Human Type I Collagen Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Human Type I Collagen Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Human Type I Collagen Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Human Type I Collagen Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Human Type I Collagen Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Human Type I Collagen Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Human Type I Collagen Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Human Type I Collagen Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Human Type I Collagen Market Segmentation & Coverage
TABLE 2. Global Human Type I Collagen Market Size, 2017-2032 (USD Million)
TABLE 3. Global Human Type I Collagen Market Size, by Form, 2017-2032 (USD Million)
TABLE 4. Global Film Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Film Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Film Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Gel Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Gel Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Gel Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Scaffold Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Scaffold Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Scaffold Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Human Type I Collagen Market Size, by Production Technique, 2017-2032 (USD Million)
TABLE 20. Global Extraction Purification Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Extraction Purification Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Extraction Purification Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Acid Solubilization Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Acid Solubilization Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Acid Solubilization Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Enzymatic Hydrolysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Enzymatic Hydrolysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Enzymatic Hydrolysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Recombinant Expression Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Recombinant Expression Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Recombinant Expression Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Bacterial Expression Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Bacterial Expression Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Bacterial Expression Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Mammalian Expression Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Mammalian Expression Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Mammalian Expression Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Yeast Expression Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Yeast Expression Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Yeast Expression Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Human Type I Collagen Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 42. Global Cosmetic Grade Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Cosmetic Grade Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Cosmetic Grade Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Laboratory Grade Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Laboratory Grade Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Laboratory Grade Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Medical Grade Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Medical Grade Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Medical Grade Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Nutraceutical Grade Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Nutraceutical Grade Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Nutraceutical Grade Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Human Type I Collagen Market Size, by Application, 2017-2032 (USD Million)
TABLE 55. Global Cosmetic Formulations Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Cosmetic Formulations Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Cosmetic Formulations Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Anti-Aging Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Anti-Aging Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Anti-Aging Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Skincare Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Skincare Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Skincare Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Dental Applications Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Dental Applications Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Dental Applications Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Dental Implants Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Dental Implants Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Dental Implants Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Periodontal Regeneration Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Periodontal Regeneration Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Periodontal Regeneration Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Drug Delivery Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Drug Delivery Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Drug Delivery Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Controlled Release Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Controlled Release Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Controlled Release Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Targeted Delivery Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Targeted Delivery Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Targeted Delivery Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Orthopedic Implants Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Orthopedic Implants Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Orthopedic Implants Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Bone Grafting Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Bone Grafting Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Bone Grafting Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Tendon Repair Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Tendon Repair Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Tendon Repair Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Wound Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Wound Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Wound Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Acute Wounds Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Acute Wounds Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Acute Wounds Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Chronic Wounds Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Chronic Wounds Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Chronic Wounds Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Surgical Wounds Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Surgical Wounds Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Surgical Wounds Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Human Type I Collagen Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Cosmetic Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Cosmetic Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Cosmetic Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Human Type I Collagen Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Asia-Pacific Human Type I Collagen Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Asia-Pacific Human Type I Collagen Market Size, by Form, 2017-2032 (USD Million)
TABLE 122. Asia-Pacific Human Type I Collagen Market Size, by Production Technique, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific Human Type I Collagen Market Size, by Extraction Purification, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific Human Type I Collagen Market Size, by Recombinant Expression, 2017-2032 (USD Million)
TABLE 125. Asia-Pacific Human Type I Collagen Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific Human Type I Collagen Market Size, by Application, 2017-2032 (USD Million)
TABLE 127. Asia-Pacific Human Type I Collagen Market Size, by Cosmetic Formulations, 2017-2032 (USD Million)
TABLE 128. Asia-Pacific Human Type I Collagen Market Size, by Dental Applications, 2017-2032 (USD Million)
TABLE 129. Asia-Pacific Human Type I Collagen Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 130. Asia-Pacific Human Type I Collagen Market Size, by Orthopedic Implants, 2017-2032 (USD Million)
TABLE 131. Asia-Pacific Human Type I Collagen Market Size, by Wound Care, 2017-2032 (USD Million)
TABLE 132. Asia-Pacific Human Type I Collagen Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. North America Human Type I Collagen Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. North America Human Type I Collagen Market Size, by Form, 2017-2032 (USD Million)
TABLE 135. North America Human Type I Collagen Market Size, by Production Technique, 2017-2032 (USD Million)
TABLE 136. North America Human Type I Collagen Market Size, by Extraction Purification, 2017-2032 (USD Million)
TABLE 137. North America Human Type I Collagen Market Size, by Recombinant Expression, 2017-2032 (USD Million)
TABLE 138. North America Human Type I Collagen Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 139. North America Human Type I Collagen Market Size, by Application, 2017-2032 (USD Million)
TABLE 140. North America Human Type I Collagen Market Size, by Cosmetic Formulations, 2017-2032 (USD Million)
TABLE 141. North America Human Type I Collagen Market Size, by Dental Applications, 2017-2032 (USD Million)
TABLE 142. North America Human Type I Collagen Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 143. North America Human Type I Collagen Market Size, by Orthopedic Implants, 2017-2032 (USD Million)
TABLE 144. North America Human Type I Collagen Market Size, by Wound Care, 2017-2032 (USD Million)
TABLE 145. North America Human Type I Collagen Market Size, by End User, 2017-2032 (USD Million)
TABLE 146. Latin America Human Type I Collagen Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Latin America Human Type I Collagen Market Size, by Form, 2017-2032 (USD Million)
TABLE 148. Latin America Human Type I Collagen Market Size, by Production Technique, 2017-2032 (USD Million)
TABLE 149. Latin America Human Type I Collagen Market Size, by Extraction Purification, 2017-2032 (USD Million)
TABLE 150. Latin America Human Type I Collagen Market Size, by Recombinant Expression, 2017-2032 (USD Million)
TABLE 151. Latin America Human Type I Collagen Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 152. Latin America Human Type I Collagen Market Size, by Application, 2017-2032 (USD Million)
TABLE 153. Latin America Human Type I Collagen Market Size, by Cosmetic Formulations, 2017-2032 (USD Million)
TABLE 154. Latin America Human Type I Collagen Market Size, by Dental Applications, 2017-2032 (USD Million)
TABLE 155. Latin America Human Type I Collagen Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 156. Latin America Human Type I Collagen Market Size, by Orthopedic Implants, 2017-2032 (USD Million)
TABLE 157. Latin America Human Type I Collagen Market Size, by Wound Care, 2017-2032 (USD Million)
TABLE 158. Latin America Human Type I Collagen Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. Europe Human Type I Collagen Market Size, by Region, 2017-2032 (USD Million)
TABLE 160. Europe Human Type I Collagen Market Size, by Form, 2017-2032 (USD Million)
TABLE 161. Europe Human Type I Collagen Market Size, by Production Technique, 2017-2032 (USD Million)
TABLE 162. Europe Human Type I Collagen Market Size, by Extraction Purification, 2017-2032 (USD Million)
TABLE 163. Europe Human Type I Collagen Market Size, by Recombinant Expression, 2017-2032 (USD Million)
TABLE 164. Europe Human Type I Collagen Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 165. Europe Human Type I Collagen Market Size, by Application, 2017-2032 (USD Million)
TABLE 166. Europe Human Type I Collagen Market Size, by Cosmetic Formulations, 2017-2032 (USD Million)
TABLE 167. Europe Human Type I Collagen Market Size, by Dental Applications, 2017-2032 (USD Million)
TABLE 168. Europe Human Type I Collagen Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 169. Europe Human Type I Collagen Market Size, by Orthopedic Implants, 2017-2032 (USD Million)
TABLE 170. Europe Human Type I Collagen Market Size, by Wound Care, 2017-2032 (USD Million)
TABLE 171. Europe Human Type I Collagen Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. Middle East Human Type I Collagen Market Size, by Region, 2017-2032 (USD Million)
TABLE 173. Middle East Human Type I Collagen Market Size, by Form, 2017-2032 (USD Million)
TABLE 174. Middle East Human Type I Collagen Market Size, by Production Technique, 2017-2032 (USD Million)
TABLE 175. Middle East Human Type I Collagen Market Size, by Extraction Purification, 2017-2032 (USD Million)
TABLE 176. Middle East Human Type I Collagen Market Size, by Recombinant Expression, 2017-2032 (USD Million)
TABLE 177. Middle East Human Type I Collagen Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 178. Middle East Human Type I Collagen Market Size, by Application, 2017-2032 (USD Million)
TABLE 179. Middle East Human Type I Collagen Market Size, by Cosmetic Formulations, 2017-2032 (USD Million)
TABLE 180. Middle East Human Type I Collagen Market Size, by Dental Applications, 2017-2032 (USD Million)
TABLE 181. Middle East Human Type I Collagen Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 182. Middle East Human Type I Collagen Market Size, by Orthopedic Implants, 2017-2032 (USD Million)
TABLE 183. Middle East Human Type I Collagen Market Size, by Wound Care, 2017-2032 (USD Million)
TABLE 184. Middle East Human Type I Collagen Market Size, by End User, 2017-2032 (USD Million)
TABLE 185. Africa Human Type I Collagen Market Size, by Region, 2017-2032 (USD Million)
TABLE 186. Africa Human Type I Collagen Market Size, by Form, 2017-2032 (USD Million)
TABLE 187. Africa Human Type I Collagen Market Size, by Production Technique, 2017-2032 (USD Million)
TABLE 188. Africa Human Type I Collagen Market Size, by Extraction Purification, 2017-2032 (USD Million)
TABLE 189. Africa Human Type I Collagen Market Size, by Recombinant Expression, 2017-2032 (USD Million)
TABLE 190. Africa Human Type I Collagen Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 191. Africa Human Type I Collagen Market Size, by Application, 2017-2032 (USD Million)
TABLE 192. Africa Human Type I Collagen Market Size, by Cosmetic Formulations, 2017-2032 (USD Million)
TABLE 193. Africa Human Type I Collagen Market Size, by Dental Applications, 2017-2032 (USD Million)
TABLE 194. Africa Human Type I Collagen Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 195. Africa Human Type I Collagen Market Size, by Orthopedic Implants, 2017-2032 (USD Million)
TABLE 196. Africa Human Type I Collagen Market Size, by Wound Care, 2017-2032 (USD Million)
TABLE 197. Africa Human Type I Collagen Market Size, by End User, 2017-2032 (USD Million)
TABLE 198. Global Human Type I Collagen Market Size, by Group, 2017-2032 (USD Million)
TABLE 199. ASEAN Human Type I Collagen Market Size, by Group, 2017-2032 (USD Million)
TABLE 200. ASEAN Human Type I Collagen Market Size, by Form, 2017-2032 (USD Million)
TABLE 201. ASEAN Human Type I Collagen Market Size, by Production Technique, 2017-2032 (USD Million)
TABLE 202. ASEAN Human Type I Collagen Market Size, by Extraction Purification, 2017-2032 (USD Million)
TABLE 203. ASEAN Human Type I Collagen Market Size, by Recombinant Expression, 2017-2032 (USD Million)
TABLE 204. ASEAN Human Type I Collagen Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 205. ASEAN Human Type I Collagen Market Size, by Application, 2017-2032 (USD Million)
TABLE 206. ASEAN Human Type I Collagen Market Size, by Cosmetic Formulations, 2017-2032 (USD Million)
TABLE 207. ASEAN Human Type I Collagen Market Size, by Dental Applications, 2017-2032 (USD Million)
TABLE 208. ASEAN Human Type I Collagen Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 209. ASEAN Human Type I Collagen Market Size, by Orthopedic Implants, 2017-2032 (USD Million)
TABLE 210. ASEAN Human Type I Collagen Market Size, by Wound Care, 2017-2032 (USD Million)
TABLE 211. ASEAN Human Type I Collagen Market Size, by End User, 2017-2032 (USD Million)
TABLE 212. GCC Human Type I Collagen Market Size, by Group, 2017-2032 (USD Million)
TABLE 213. GCC Human Type I Collagen Market Size, by Form, 2017-2032 (USD Million)
TABLE 214. GCC Human Type I Collagen Market Size, by Production Technique, 2017-2032 (USD Million)
TABLE 215. GCC Human Type I Collagen Market Size, by Extraction Purification, 2017-2032 (USD Million)
TABLE 216. GCC Human Type I Collagen Market Size, by Recombinant Expression, 2017-2032 (USD Million)
TABLE 217. GCC Human Type I Collagen Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 218. GCC Human Type I Collagen Market Size, by Application, 2017-2032 (USD Million)
TABLE 219. GCC Human Type I Collagen Market Size, by Cosmetic Formulations, 2017-2032 (USD Million)
TABLE 220. GCC Human Type I Collagen Market Size, by Dental Applications, 2017-2032 (USD Million)
TABLE 221. GCC Human Type I Collagen Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 222. GCC Human Type I Collagen Market Size, by Orthopedic Implants, 2017-2032 (USD Million)
TABLE 223. GCC Human Type I Collagen Market Size, by Wound Care, 2017-2032 (USD Million)
TABLE 224. GCC Human Type I Collagen Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. European Union Human Type I Collagen Market Size, by Group, 2017-2032 (USD Million)
TABLE 226. European Union Human Type I Collagen Market Size, by Form, 2017-2032 (USD Million)
TABLE 227. European Union Human Type I Collagen Market Size, by Production Technique, 2017-2032 (USD Million)
TABLE 228. European Union Human Type I Collagen Market Size, by Extraction Purification, 2017-2032 (USD Million)
TABLE 229. European Union Human Type I Collagen Market Size, by Recombinant Expression, 2017-2032 (USD Million)
TABLE 230. European Union Human Type I Collagen Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 231. European Union Human Type I Collagen Market Size, by Application, 2017-2032 (USD Million)
TABLE 232. European Union Human Type I Collagen Market Size, by Cosmetic Formulations, 2017-2032 (USD Million)
TABLE 233. European Union Human Type I Collagen Market Size, by Dental Applications, 2017-2032 (USD Million)
TABLE 234. European Union Human Type I Collagen Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 235. European Union Human Type I Collagen Market Size, by Orthopedic Implants, 2017-2032 (USD Million)
TABLE 236. European Union Human Type I Collagen Market Size, by Wound Care, 2017-2032 (USD Million)
TABLE 237. European Union Human Type I Collagen Market Size, by End User, 2017-2032 (USD Million)
TABLE 238. BRICS Human Type I Collagen Market Size, by Group, 2017-2032 (USD Million)
TABLE 239. BRICS Human Type I Collagen Market Size, by Form, 2017-2032 (USD Million)
TABLE 240. BRICS Human Type I Collagen Market Size, by Production Technique, 2017-2032 (USD Million)
TABLE 241. BRICS Human Type I Collagen Market Size, by Extraction Purification, 2017-2032 (USD Million)
TABLE 242. BRICS Human Type I Collagen Market Size, by Recombinant Expression, 2017-2032 (USD Million)
TABLE 243. BRICS Human Type I Collagen Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 244. BRICS Human Type I Collagen Market Size, by Application, 2017-2032 (USD Million)
TABLE 245. BRICS Human Type I Collagen Market Size, by Cosmetic Formulations, 2017-2032 (USD Million)
TABLE 246. BRICS Human Type I Collagen Market Size, by Dental Applications, 2017-2032 (USD Million)
TABLE 247. BRICS Human Type I Collagen Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 248. BRICS Human Type I Collagen Market Size, by Orthopedic Implants, 2017-2032 (USD Million)
TABLE 249. BRICS Human Type I Collagen Market Size, by Wound Care, 2017-2032 (USD Million)
TABLE 250. BRICS Human Type I Collagen Market Size, by End User, 2017-2032 (USD Million)
TABLE 251. G7 Human Type I Collagen Market Size, by Group, 2017-2032 (USD Million)
TABLE 252. G7 Human Type I Collagen Market Size, by Form, 2017-2032 (USD Million)
TABLE 253. G7 Human Type I Collagen Market Size, by Production Technique, 2017-2032 (USD Million)
TABLE 254. G7 Human Type I Collagen Market Size, by Extraction Purification, 2017-2032 (USD Million)
TABLE 255. G7 Human Type I Collagen Market Size, by Recombinant Expression, 2017-2032 (USD Million)
TABLE 256. G7 Human Type I Collagen Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 257. G7 Human Type I Collagen Market Size, by Application, 2017-2032 (USD Million)
TABLE 258. G7 Human Type I Collagen Market Size, by Cosmetic Formulations, 2017-2032 (USD Million)
TABLE 259. G7 Human Type I Collagen Market Size, by Dental Applications, 2017-2032 (USD Million)
TABLE 260. G7 Human Type I Collagen Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 261. G7 Human Type I Collagen Market Size, by Orthopedic Implants, 2017-2032 (USD Million)
TABLE 262. G7 Human Type I Collagen Market Size, by Wound Care, 2017-2032 (USD Million)
TABLE 263. G7 Human Type I Collagen Market Size, by End User, 2017-2032 (USD Million)
TABLE 264. NATO Human Type I Collagen Market Size, by Group, 2017-2032 (USD Million)
TABLE 265. NATO Human Type I Collagen Market Size, by Form, 2017-2032 (USD Million)
TABLE 266. NATO Human Type I Collagen Market Size, by Production Technique, 2017-2032 (USD Million)
TABLE 267. NATO Human Type I Collagen Market Size, by Extraction Purification, 2017-2032 (USD Million)
TABLE 268. NATO Human Type I Collagen Market Size, by Recombinant Expression, 2017-2032 (USD Million)
TABLE 269. NATO Human Type I Collagen Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 270. NATO Human Type I Collagen Market Size, by Application, 2017-2032 (USD Million)
TABLE 271. NATO Human Type I Collagen Market Size, by Cosmetic Formulations, 2017-2032 (USD Million)
TABLE 272. NATO Human Type I Collagen Market Size, by Dental Applications, 2017-2032 (USD Million)
TABLE 273. NATO Human Type I Collagen Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 274. NATO Human Type I Collagen Market Size, by Orthopedic Implants, 2017-2032 (USD Million)
TABLE 275. NATO Human Type I Collagen Market Size, by Wound Care, 2017-2032 (USD Million)
TABLE 276. NATO Human Type I Collagen Market Size, by End User, 2017-2032 (USD Million)
TABLE 277. Global Human Type I Collagen Market Size, by Country, 2017-2032 (USD Million)
TABLE 278. United States Human Type I Collagen Market Size, 2017-2032 (USD Million)
TABLE 279. United States Human Type I Collagen Market Size, by Form, 2017-2032 (USD Million)
TABLE 280. United States Human Type I Collagen Market Size, by Production Technique, 2017-2032 (USD Million)
TABLE 281. United States Human Type I Collagen Market Size, by Extraction Purification, 2017-2032 (USD Million)
TABLE 282. United States Human Type I Collagen Market Size, by Recombinant Expression, 2017-2032 (USD Million)
TABLE 283. United States Human Type I Collagen Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 284. United States Human Type I Collagen Market Size, by Application, 2017-2032 (USD Million)
TABLE 285. United States Human Type I Collagen Market Size, by Cosmetic Formulations, 2017-2032 (USD Million)
TABLE 286. United States Human Type I Collagen Market Size, by Dental Applications, 2017-2032 (USD Million)
TABLE 287. United States Human Type I Collagen Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 288. United States Human Type I Collagen Market Size, by Orthopedic Implants, 2017-2032 (USD Million)
TABLE 289. United States Human Type I Collagen Market Size, by Wound Care, 2017-2032 (USD Million)
TABLE 290. United States Human Type I Collagen Market Size, by End User, 2017-2032 (USD Million)
TABLE 291. Canada Human Type I Collagen Market Size, 2017-2032 (USD Million)
TABLE 292. Canada Human Type I Collagen Market Size, by Form, 2017-2032 (USD Million)
TABLE 293. Canada Human Type I Collagen Market Size, by Production Technique, 2017-2032 (USD Million)
TABLE 294. Canada Human Type I Collagen Market Size, by Extraction Purification, 2017-2032 (USD Million)
TABLE 295. Canada Human Type I Collagen Market Size, by Recombinant Expression, 2017-2032 (USD Million)
TABLE 296. Canada Human Type I Collagen Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 297. Canada Human Type I Collagen Market Size, by Application, 2017-2032 (USD Million)
TABLE 298. Canada Human Type I Collagen Market Size, by Cosmetic Formulations, 2017-2032 (USD Million)
TABLE 299. Canada Human Type I Collagen Market Size, by Dental Applications, 2017-2032 (USD Million)
TABLE 300. Canada Human Type I Collagen Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 301. Canada Human Type I Collagen Market Size, by Orthopedic Implants, 2017-2032 (USD Million)
TABLE 302. Canada Human Type I Collagen Market Size, by Wound Care, 2017-2032 (USD Million)
TABLE 303. Canada Human Type I Collagen Market Size, by End User, 2017-2032 (USD Million)
TABLE 304. Mexico Human Type I Collagen Market Size, 2017-2032 (USD Million)
TABLE 305. Mexico Human Type I Collagen Market Size, by Form, 2017-2032 (USD Million)
TABLE 306. Mexico Human Type I Collagen Market Size, by Production Technique, 2017-2032 (USD Million)
TABLE 307. Mexico Human Type I Collagen Market Size, by Extraction Purification, 2017-2032 (USD Million)
TABLE 308. Mexico Human Type I Collagen Market Size, by Recombinant Expression, 2017-2032 (USD Million)
TABLE 309. Mexico Human Type I Collagen Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 310. Mexico Human Type I Collagen Market Size, by Application, 2017-2032 (USD Million)
TABLE 311. Mexico Human Type I Collagen Market Size, by Cosmetic Formulations, 2017-2032 (USD Million)
TABLE 312. Mexico Human Type I Collagen Market Size, by Dental Applications, 2017-2032 (USD Million)
TABLE 313. Mexico Human Type I Collagen Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 314. Mexico Human Type I Collagen Market Size, by Orthopedic Implants, 2017-2032 (USD Million)
TABLE 315. Mexico Human Type I Collagen Market Size, by Wound Care, 2017-2032 (USD Million)
TABLE 316. Mexico Human Type I Collagen Market Size, by End User, 2017-2032 (USD Million)
TABLE 317. Brazil Human Type I Collagen Market Size, 2017-2032 (USD Million)
TABLE 318. Brazil Human Type I Collagen Market Size, by Form, 2017-2032 (USD Million)
TABLE 319. Brazil Human Type I Collagen Market Size, by Production Technique, 2017-2032 (USD Million)
TABLE 320. Brazil Human Type I Collagen Market Size, by Extraction Purification, 2017-2032 (USD Million)
TABLE 321. Brazil Human Type I Collagen Market Size, by Recombinant Expression, 2017-2032 (USD Million)
TABLE 322. Brazil Human Type I Collagen Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 323. Brazil Human Type I Collagen Market Size, by Application, 2017-2032 (USD Million)
TABLE 324. Brazil Human Type I Collagen Market Size, by Cosmetic Formulations, 2017-2032 (USD Million)
TABLE 325. Brazil Human Type I Collagen Market Size, by Dental Applications, 2017-2032 (USD Million)
TABLE 326. Brazil Human Type I Collagen Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 327. Brazil Human Type I Collagen Market Size, by Orthopedic Implants, 2017-2032 (USD Million)
TABLE 328. Brazil Human Type I Collagen Market Size, by Wound Care, 2017-2032 (USD Million)
TABLE 329. Brazil Human Type I Collagen Market Size, by End User, 2017-2032 (USD Million)
TABLE 330. United Kingdom Human Type I Collagen Market Size, 2017-2032 (USD Million)
TABLE 331. United Kingdom Human Type I Collagen Market Size, by Form, 2017-2032 (USD Million)
TABLE 332. United Kingdom Human Type I Collagen Market Size, by Production Technique, 2017-2032 (USD Million)
TABLE 333. United Kingdom Human Type I Collagen Market Size, by Extraction Purification, 2017-2032 (USD Million)
TABLE 334. United Kingdom Human Type I Collagen Market Size, by Recombinant Expression, 2017-2032 (USD Million)
TABLE 335. United Kingdom Human Type I Collagen Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 336. United Kingdom Human Type I Collagen Market Size, by Application, 2017-2032 (USD Million)
TABLE 337. United Kingdom Human Type I Collagen Market Size, by Cosmetic Formulations, 2017-2032 (USD Million)
TABLE 338. United Kingdom Human Type I Collagen Market Size, by Dental Applications, 2017-2032 (USD Million)
TABLE 339. United Kingdom Human Type I Collagen Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 340. United Kingdom Human Type I Collagen Market Size, by Orthopedic Implants, 2017-2032 (USD Million)
TABLE 341. United Kingdom Human Type I Collagen Market Size, by Wound Care, 2017-2032 (USD Million)
TABLE 342. United Kingdom Human Type I Collagen Market Size, by End User, 2017-2032 (USD Million)
TABLE 343. Germany Human Type I Collagen Market Size, 2017-2032 (USD Million)
TABLE 344. Germany Human Type I Collagen Market Size, by Form, 2017-2032 (USD Million)
TABLE 345. Germany Human Type I Collagen Market Size, by Production Technique, 2017-2032 (USD Million)
TABLE 346. Germany Human Type I Collagen Market Size, by Extraction Purification, 2017-2032 (USD Million)
TABLE 347. Germany Human Type I Collagen Market Size, by Recombinant Expression, 2017-2032 (USD Million)
TABLE 348. Germany Human Type I Collagen Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 349. Germany Human Type I Collagen Market Size, by Application, 2017-2032 (USD Million)
TABLE 350. Germany Human Type I Collagen Market Size, by Cosmetic Formulations, 2017-2032 (USD Million)
TABLE 351. Germany Human Type I Collagen Market Size, by Dental Applications, 2017-2032 (USD Million)
TABLE 352. Germany Human Type I Collagen Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 353. Germany Human Type I Collagen Market Size, by Orthopedic Implants, 2017-2032 (USD Million)
TABLE 354. Germany Human Type I Collagen Market Size, by Wound Care, 2017-2032 (USD Milli

Companies Mentioned

  • Advanced BioMatrix, Inc.
  • B. Braun Melsungen AG
  • Biomatlante
  • Botiss Biomaterials GmbH
  • Collagen GmbH
  • Collagen Matrix, Inc.
  • Collagen Solutions plc
  • CollPlant Biotechnologies Ltd.
  • Covalon Technologies Ltd.
  • Devro plc
  • DSM Biomedical
  • EnColl Corporation
  • FibroGen, Inc.
  • Gurnet Point Capital
  • Integra LifeSciences Corporation
  • Jellagen Pty Ltd
  • Kensey Nash Corporation
  • Medtronic plc
  • Regenity Biosciences
  • Sunmax Biotechnology Co., Ltd.
  • Viscofan BioEngineering
  • Xylos Corporation
  • Zimmer Biomet Holdings, Inc.